A phase II trial of intraluminal irrigation with recombinant human tissue factor pathway inhibitor to prevent thrombosis in free flap surgery

Plastic and Reconstructive Surgery

Volumn 107, Issue 2, 2001, Pages 408-415

  Khouri, R K ^a   Sherman, R ^a   Buncke H J , Jr ^a   Feller, A M ^a   Hovius, S ^a   Benes, C O ^a   Ingram, D M ^a   Natarajan, N N ^a   Sherman, J W ^a   Yeramian, P D ^a   Cooley, B C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SCH 59735; TISSUE FACTOR PATHWAY INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTERY ANASTOMOSIS; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FREE TISSUE GRAFT; GRAFT FAILURE; HEMATOMA; HUMAN; INTESTINE LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; VEIN ANASTOMOSIS; GRAFT PATENCY; NOTE; SURGICAL RISK;

EID: 0035146330     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200102000-00016     Document Type: Article

References (41)

1. Autotransplant of omentum to a large scalp defect, with microsurgical revascularization
2. Distant transfer of an island flap by microvascular anastomoses: A clinical technique
3. The radial forearm flap in intraoral reconstruction: The experience of 60 consecutive cases
4. Experience with one hundred consecutive free flaps
5. Analysis of 200 free flaps
6. Complications and vascular salvage of free-tissue transfers to the extremities
7. Reconstruction of the lower extremity with microvascular free flaps: A 10-year experience with 304 consecutive cases
8. Post-trauma reconstruction with free tissue transfer: Analysis of 442 consecutive cases
9. Microvascular free-tissue transfer
10. Free flap surgery: The Welsh Regional Unit experience
11. The role of emergent exploration in free-tissue transfer: A review of 150 consecutive cases
12. Free-tissue transfer in elderly patients
13. Microvascular tissue transfer in paediatric patients: Analysis of 106 cases
14. Salvage of wounds following failed tissue transplantation
15. Microvascular free flaps in head and neck surgery
16. Morbidity associated with free-tissue transfer after radiotherapy and chemotherapy in elderly cancer patients
17. Advanced patient age should not preclude the use of free flap reconstruction for head and neck cancer
18. Anticoagulants and hematomas in free flap surgery
19. A world survey of anticoagulation practice in clinical microvascular surgery
20. International survey of current microvascular practices in free tissue transfer and replantation surgery
21. A prospective study of microvascular free-flap surgery and outcome
22. Avoiding free flap failure
23. Investigation in the use of topical solutions for management or prevention of thrombosis in traumatized vessels
24. A comparison of irrigation solutions for microanastomoses
25. Maintenance of patency following vascular trauma by topical irrigation with peptide homologous to the carboxy-terminus of the fibrinogen gamma-chain
26. The importance of topical heparin in microvascular anastomoses: A study in the rat
27. A comparison of heparinised saline irrigation solutions in a model of microvascular thrombosis
28. Topical heparin enhances patency in a rat model of arterial thrombosis
29. Washout of vessels with heparin does not improve patency following severe microarterial trauma: An experimental study
30. Effect of heparinized irrigating solutions on patency of experimental microvascular anastomoses
31. Influence of topical heparin on stasis-induced thrombosis of microvascular anastomoses
32. Comparison of the influence of intraluminal irrigation solutions on free flap survival
33. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells
34. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
35. Regulation of coagulation by a multivalent Kunitz-type inhibitor
36. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells
37. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli
38. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
39. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma
40. Prevention of microvascular thrombosis by topical application of tissue factor pathway inhibitor
41. Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors